November 18, 2024   USA

“We need to engage with key players in the healthcare system, secure support among prescribers, and position Diamyd Medical effectively within the U.S. market,” says Diamyd Medical board member Karin Rosen, MD PhD.

Read the article here

Silicon Valley Nordic Beat summarizes the webcast on November 14 where CEO Ulf Hannelius, Board Member Karin Rosen MD, PhD, and Head of Business Development Sofia Mayans presented the company.

See full webcast (in Swedish) here:

Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.